EGFR exon 19 deletion + EGFR L861Q
|
LUAD
|
EGFR exon 19 deletion + EGFR L861Q
|
LUAD
|
afatinib Sensitive: D – Preclinical
Clin Transl Oncol - 3 weeks (New D)
|
afatinib Sensitive: D – Preclinical
Clin Transl Oncol - 3 weeks - (New D)
|
EGFR exon 19 deletion + EGFR L861Q
|
LUAD
|
EGFR exon 19 deletion + EGFR L861Q
|
LUAD
|
osimertinib Sensitive: D – Preclinical
Clin Transl Oncol - 3 weeks (New D)
|
osimertinib Sensitive: D – Preclinical
Clin Transl Oncol - 3 weeks - (New D)
|
EGFR exon 19 deletion + EGFR L861Q
|
LUAD
|
EGFR exon 19 deletion + EGFR L861Q
|
LUAD
|
dacomitinib Sensitive: D – Preclinical
Clin Transl Oncol - 3 weeks (New D)
|
dacomitinib Sensitive: D – Preclinical
Clin Transl Oncol - 3 weeks - (New D)
|
EGFR exon 19 deletion + EGFR L861Q
|
LUAD
|
EGFR exon 19 deletion + EGFR L861Q
|
LUAD
|
icotinib Sensitive: D – Preclinical
Clin Transl Oncol - 3 weeks (New D)
|
icotinib Sensitive: D – Preclinical
Clin Transl Oncol - 3 weeks - (New D)
|
EGFR exon 19 deletion + EGFR L861Q
|
LUAD
|
EGFR exon 19 deletion + EGFR L861Q
|
LUAD
|
erlotinib Sensitive: D – Preclinical
Clin Transl Oncol - 3 weeks (New D)
|
erlotinib Sensitive: D – Preclinical
Clin Transl Oncol - 3 weeks - (New D)
|
EGFR exon 19 deletion + EGFR L861Q
|
LUAD
|
EGFR exon 19 deletion + EGFR L861Q
|
LUAD
|
gefitinib Sensitive: D – Preclinical
Clin Transl Oncol - 3 weeks (New D)
|
gefitinib Sensitive: D – Preclinical
Clin Transl Oncol - 3 weeks - (New D)
|